Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Combining bromelain with finasteride improves hair regrowth and reduces inflammation in alopecia.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Betamethasone valerate lotion is more effective for treating multiple patchy alopecia areata.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Upadacitinib effectively treats severe alopecia areata and is safe.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.